We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

IFCC Celebrates 70 Years of Advancing Science of Laboratory Medicine and In Vitro Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2022
Print article
Image: IFCC’s achievements have advanced the science of laboratory medicine and in vitro diagnostics (Photo courtesy of IFCC)
Image: IFCC’s achievements have advanced the science of laboratory medicine and in vitro diagnostics (Photo courtesy of IFCC)

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC, Milano, Italy) is celebrating 70 years (1952 – 2022) of enormous achievements that have been extraordinary and impressive. Many important milestones have been accomplished contributing to the IFCC’s mission of “Advancing excellence in laboratory medicine for better healthcare worldwide”.

Particularly remarkable are the many golden achievements by the Scientific Division, Education and Management Division, Communications and Publications Division, and the Emerging Technology Division. Clearly, these achievements have not only contributed to the growth of the IFCC organization but have also had important impact on advancing the science of laboratory medicine and in vitro diagnostics around the world.

“I strongly believe that the future holds considerable promise for the IFCC organization and its family of national societies and corporate members,” said Professor Khosrow Adeli, IFCC President. “The strong foundation built by thousands of IFCC officers over the past two decades as highlighted in this report will ensure the IFCC’s continued journey towards global leadership in laboratory medicine, contributing to its most valuable mission of improving clinical decision making and better healthcare worldwide.”

“Many new initiatives are planned over the coming years to further enhance IFCC’s leadership position and increase IFCC’s role in improving global healthcare and improved patient outcomes,” added Professor Khosrow Adeli. “There will be major expansions of the IFCC’s role in global lab quality to improve internal and external quality assurance and in distance learning resources to enhance continuing education for clinical laboratory professionals worldwide. I have no doubt that IFCC will continue to shine and excel, thanks to the contributions of thousands of dedicated scientists who have actively participated and will continue to participate in numerous functional units within the IFCC organization.”

Related Links:
IFCC 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more